Practical articles for healthcare providers on peptide therapy, program design, regulatory considerations, and clinical applications. Written for the providers who actually run the programs.
The compliance, education, and follow-up gaps that kill most peptide programs in their first six months, and the structural fix for each.
Read article →The peptide formulations with the highest patient demand, the cleanest clinical use cases, and the strongest re-order economics for wellness practices.
Read article →The peptide protocols, patient conversation flows, and program economics that work inside chiropractic practices. A practical guide for DCs.
Read article →How aesthetic practices integrate oral dissolving peptide therapy into existing service menus, with the formulations, pricing structures, and patient conversations that work.
Read article →The inventory framework for stocking peptides without tying up cash, running out at peak demand, or letting product sit past optimum freshness.
Read article →The regulatory and operational realities of oral dissolving peptide therapy compared to injectable programs, and which practice types qualify for which products.
Read article →The comparison between NAD+ delivered as oral dissolving strips versus IV infusion. Bioavailability, cost, patient experience, and operational complexity.
Read article →The clinical and operational comparison between BPC-157 delivered as an oral dissolving strip versus a compounded injectable, including bioavailability and adherence data.
Read article →What the published research says about GHK-Cu copper peptide for collagen synthesis, skin rejuvenation, and wound healing. A clinical reference for providers.
Read article →The science behind sublingual peptide delivery, why bioavailability for buccal absorption rivals injection, and how this changes peptide therapy access for clinics.
Read article →